Page
%P
2 Result(s)
within
Michael S. Chimenti
Immunology
-
Article
Open AccessT cells, particularly activated CD4+ cells, maintain anti-CD20-mediated NK cell viability and antibody dependent cellular cytotoxicity
Anti-CD20 monoclonal antibody (mAb) therapy is a mainstay of therapy for B cell malignancies, however many patients fail to respond or eventually develop resistance. The current understanding of mechanisms res...
-
Article
Open AccessTraumatic brain injury results in unique microglial and astrocyte transcriptomes enriched for type I interferon response
Traumatic brain injury (TBI) is a leading cause of death and disability that lacks neuroprotective therapies. Following a TBI, secondary injury response pathways are activated and contribute to ongoing neurode...
